102 related articles for article (PubMed ID: 16025494)
1. Hepatitis B viral kinetics: a dynamic puzzle still to be resolved.
Neumann AU
Hepatology; 2005 Aug; 42(2):249-54. PubMed ID: 16025494
[No Abstract] [Full Text] [Related]
2. Predicting treatment outcomes for HBV patients.
AIDS Patient Care STDS; 2009 Mar; 23(3):223. PubMed ID: 19480059
[No Abstract] [Full Text] [Related]
3. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
Song K; Rajvanshi P
N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16221792
[No Abstract] [Full Text] [Related]
4. Peginterferon and lamivudine for hepatitis B.
Assy NN; Hussein O
N Engl J Med; 2004 Dec; 351(27):2879; author reply 2879. PubMed ID: 15625344
[No Abstract] [Full Text] [Related]
5. The maze of treatments for hepatitis B.
Lok AS
N Engl J Med; 2005 Jun; 352(26):2743-6. PubMed ID: 15987924
[No Abstract] [Full Text] [Related]
6. [Advance in clinical studies of the kinetics of hepatitis B virus].
Tang YT; Cao Q; Zhang DZ
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):75-7. PubMed ID: 20128981
[No Abstract] [Full Text] [Related]
7. [Protocol for the antiviral therapy of hepatitis B and D].
; ; Gervain J; Horváth G; Hunyady B; Makara M; Pár A; Szalay F; Tornai I; Telegdy L
Orv Hetil; 2010 Jan; 151(1):24-8. PubMed ID: 20031523
[No Abstract] [Full Text] [Related]
8. Does the addition of lamivudine to peginterferon alpha-2a sustain response rates in HBeAg-negative hepatitis B?
Cooksley G
Nat Clin Pract Gastroenterol Hepatol; 2005 Jan; 2(1):12-3. PubMed ID: 16265091
[No Abstract] [Full Text] [Related]
9. To genotype or not to genotype: toward an optimal tailoring of treatment of chronic hepatitis B.
Lin CL; Kao JH
Clin Infect Dis; 2007 Jun; 44(12):1665-6. PubMed ID: 17516416
[No Abstract] [Full Text] [Related]
10. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
Z Gastroenterol; 2007 Dec; 45(12):1281-328. PubMed ID: 18080231
[No Abstract] [Full Text] [Related]
11. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication.
Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J
Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899
[TBL] [Abstract][Full Text] [Related]
12. Treatment of HBeAg-positive hepatitis B with peginterferon and lamivudine.
Orlent H
N Engl J Med; 2005 Oct; 353(15):1630-1; author reply 1630-1. PubMed ID: 16224825
[No Abstract] [Full Text] [Related]
13. The summarized of EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
Idilman R
Turk J Gastroenterol; 2017 Sep; 28(5):412-416. PubMed ID: 28936972
[No Abstract] [Full Text] [Related]
14. Combination of Pegylated Interferon and Nucleos(t)ide Therapy: Toward a Cure of Hepatitis B Virus Infection?
Cho EJ; Lee JH; Yoon JH
Gut Liver; 2016 Jul; 10(4):497-8. PubMed ID: 26198336
[No Abstract] [Full Text] [Related]
15. Treatment with interferons (including pegylated interferons) in patients with hepatitis B.
Cooksley WG
Semin Liver Dis; 2004; 24 Suppl 1():45-53. PubMed ID: 15192801
[TBL] [Abstract][Full Text] [Related]
16. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
Lau GK; Piratvisuth T; Luo KX; Marcellin P; Thongsawat S; Cooksley G; Gane E; Fried MW; Chow WC; Paik SW; Chang WY; Berg T; Flisiak R; McCloud P; Pluck N;
N Engl J Med; 2005 Jun; 352(26):2682-95. PubMed ID: 15987917
[TBL] [Abstract][Full Text] [Related]
17. [Interferon therapy for hepatitis B and C].
Iino S
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():559-63. PubMed ID: 17455681
[No Abstract] [Full Text] [Related]
18. Modelling of early viral kinetics and pegylated interferon-alpha2b pharmacokinetics in patients with HBeag-positive chronic hepatitis B.
ter Borg MJ; Hansen BE; Herrmann E; Zeuzem S; Cakaloglu Y; Karayalcin S; Flisiak R; van' t Veen A; de Man RA; Schalm SW; Janssen HL; Haagmans BL;
Antivir Ther; 2007; 12(8):1285-94. PubMed ID: 18240868
[TBL] [Abstract][Full Text] [Related]
19. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B.
Bonino F; Marcellin P; Lau GK; Hadziyannis S; Jin R; Piratvisuth T; Germanidis G; Yurdaydin C; Diago M; Gurel S; Lai MY; Brunetto MR; Farci P; Popescu M; McCloud P;
Gut; 2007 May; 56(5):699-705. PubMed ID: 17127704
[TBL] [Abstract][Full Text] [Related]
20. Viral hepatitis in HIV infection.
Koziel MJ; Peters MG
N Engl J Med; 2007 Apr; 356(14):1445-54. PubMed ID: 17409326
[No Abstract] [Full Text] [Related]
[Next] [New Search]
